help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2004-0023
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elhaji, Y. A.
Right arrow Articles by Trifiro, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elhaji, Y. A.
Right arrow Articles by Trifiro, M. A.
Molecular Endocrinology 18 (8): 1876-1886
Copyright © 2004 by The Endocrine Society

An Examination of How Different Mutations at Arginine 855 of the Androgen Receptor Result in Different Androgen Insensitivity Phenotypes

Youssef A. Elhaji, Jian Hui Wu, Bruce Gottlieb, Lenore K. Beitel, Carlos Alvarado, Gerald Batist and Mark A. Trifiro

Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital (Y.A.E., J.H.W., B.G., L.K.B., C.A., G.B., M.A.T.), Departments of Human Genetics (Y.A.E., M.A.T.), Medicine (M.A.T., L.K.B.) and Oncology (J.H.W., G.B.), McGill University, Montreal, Quebec, Canada H3T 1E2

Address all correspondence and requests for reprints to: M. A. Trifiro, M.D., Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, 3755 Cote-Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2. E-mail: mark.trifiro{at}mcgill.ca.

Two substitutions at an identical location in the ligand-binding domain (LBD) of the human androgen receptor (AR), R855C and R855H, are associated with complete androgen insensitivity syndrome (AIS) and partial AIS, respectively. Kinetic analysis of the mutant receptors in genital skin fibroblasts and in transfected cells revealed very low total binding (Bmax) and increased rate constants of dissociation (k) for the R855C mutant; and normal Bmax and k, with slightly elevated equilibrium affinity constants (Kd), but decreased transactivational capacity for the R855H mutant. Further analysis of the R855H mutant revealed both thermolability and decreased N/C-terminal inter-actions in the presence and absence of the co-activator transcriptional intermediary factor 2. To establish the nature of these functional differences we have used molecular dynamic modeling to create four-dimensional models of each of the mutant receptors. Molecular dynamic modeling produced profoundly different models for each of the mutants: in modeling of R855C a surprisingly significant distant alteration in the position of helix 12 of the helix 12 positioning of the AR ligand binding domain (AR-LBD) occurs, which would predict severe ligand binding abnormalities and complete AIS; in modeling of R855H, no dramatic effect on the position of helix 12 was seen; thus, binding properties of the receptor are not compromised.

Molecular dynamics four-dimensional modeling clearly supports the biochemical and kinetic studies of both mutants. Such novel computational modeling may lead to a better understanding of the structure-function relationships and the molecular mechanics of ligand binding not only of the AR-LBD but also of other nuclear receptors.

NURSA Molecule Pages Link:

Nuclear Receptors:   AR
Coregulators:   GRIP1
Ligands:   Dihydrotestosterone  |  R1881



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Schmidt, S.-I. Harada, D. B. Kimmel, C. Bai, F. Chen, S. J. Rutledge, R. L. Vogel, A. Scafonas, M. A. Gentile, P. V. Nantermet, et al.
Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands
J. Biol. Chem., December 25, 2009; 284(52): 36367 - 36376.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
J Jaaskelainen, A Deeb, J W Schwabe, N P Mongan, H Martin, and I A Hughes
Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.
J. Mol. Endocrinol., April 1, 2006; 36(2): 361 - 368.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Y. A. Elhaji, I. Stoica, S. Dennis, E. O. Purisima, and M. A. Trifiro
Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity
Hum. Mol. Genet., March 15, 2006; 15(6): 921 - 931.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society